ArticleJournal of breast cancer2021

Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab.

Joo Young Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.